Ellias' significant experience and expertise in T1D will gre...

Moomoo AI Nov 20, 2023 20:41

Ellias' significant experience and expertise in T1D will greatly benefit SAB's Board of Directors, stated Samuel J. Reich, Executive Chairman of SAB. Acknowledging the company's promising position in T1D, Ellias expressed her enthusiasm for joining SAB's Board of Directors.

Press Release: SAB Biotherapeutics Appoints Katie Ellias to the Board of Directors

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

2121 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4183Followers

0Following

9215Visitors